![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » HYPRES LANDS $100,000 DOE CONTRACT TO DEVELOP AMPLIFIER CHIP FOR MEDICAL DIAGNOSTICS, WIRELESS TECHNOLOGY
HYPRES LANDS $100,000 DOE CONTRACT TO DEVELOP AMPLIFIER CHIP FOR MEDICAL DIAGNOSTICS, WIRELESS TECHNOLOGY
September 13, 2006
HYPRES has been awarded a nine-month, $100,000 contract with the U.S. Department of Energy (DOE) to develop a low-noise superconducting quantum interference device (SQUID)-based amplifier chip for high-speed applications, the firm said Sept. 12.
The firm develops superconducting microelectronics technology. SQUIDs are superconducting Josephson junction circuits approximately 1 million times more sensitive to signals than conventional semiconductor circuits, the firm said.
The amplifier chip the firm is developing for the DOE will be used in wireless communications, noninvasive medical diagnostic instrumentation and cryogenic detector arrays, HYPRES said.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct